| Precise quantification of minimal residual disease at day 29 allows identification of children with acute lymphoblastic leukemia and an excellent outcome C Nyvold, HO Madsen, LP Ryder, J Seyfarth, A Svejgaard, N Clausen, ... Blood, The Journal of the American Society of Hematology 99 (4), 1253-1258, 2002 | 207 | 2002 |
| Harmonization of BCR-ABL mRNA quantification using a uniform multifunctional control plasmid in 37 international laboratories MC Müller, P Erben, G Saglio, E Gottardi, CG Nyvold, T Schenk, T Ernst, ... Leukemia 22 (1), 96-102, 2008 | 113 | 2008 |
| Relapse prediction in acute myeloid leukaemia patients in complete remission using WT1 as a molecular marker: development of a mathematical model to predict … HB Ommen, CG Nyvold, K Brændstrup, BL Andersen, IB Ommen, H Hasle, ... British journal of haematology 141 (6), 782-791, 2008 | 94 | 2008 |
| Chimeric antigen receptor T cells targeting CD79b show efficacy in lymphoma with or without cotargeting CD19 M Ormhøj, I Scarfò, ML Cabral, SR Bailey, SJ Lorrey, AA Bouffard, ... Clinical Cancer Research 25 (23), 7046-7057, 2019 | 70 | 2019 |
| Minimal residual core binding factor AMLs by real time quantitative PCR—Initial response to chemotherapy predicts event free survival and close monitoring of peripheral blood … J Stentoft, P Hokland, M Østergaard, H Hasle, CG Nyvold Leukemia research 30 (4), 389-395, 2006 | 67 | 2006 |
| Post-induction residual leukemia in childhood acute lymphoblastic leukemia quantified by PCR correlates with in vitro prednisolone resistance K Schmiegelow, C Nyvold, J Seyfarth, R Pieters, MMA Rottier, N Knabe, ... Leukemia 15 (7), 1066-1071, 2001 | 60 | 2001 |
| h MICL and CD 123 in combination with a CD 45/CD 34/CD 117 backbone–a universal marker combination for the detection of minimal residual disease in acute myeloid leukaemia AS Roug, HØ Larsen, L Nederby, T Just, G Brown, CG Nyvold, ... British journal of haematology 164 (2), 212-222, 2014 | 57 | 2014 |
| Molecular typing of adult acute myeloid leukaemia: significance of translocations, tandem duplications, methylation, and selective gene expression profiling LH Olesen, A Aggerholm, BL Andersen, CG Nyvold, P Guldberg, ... British journal of haematology 131 (4), 457-467, 2005 | 56 | 2005 |
| The combined expression of HOXA4 and MEIS1 is an independent prognostic factor in patients with AML M Zangenberg, L Grubach, A Aggerholm, T Silkjaer, C Juhl‐Christensen, ... European journal of haematology 83 (5), 439-448, 2009 | 42 | 2009 |
| Interleukin-21 mRNA expression during virus infections C Holm, CG Nyvold, SR Plaudan, AR Thomsen, M Hokland Cytokine 33 (1), 41-45, 2006 | 42 | 2006 |
| Interleukin-21 mRNA expression during virus infections C Holm, CG Nyvold, SR Plaudan, AR Thomsen, M Hokland Cytokine 33 (1), 41-45, 2006 | 42 | 2006 |
| Immunoelectron microscopy and mass spectrometry for classification of amyloid deposits N Abildgaard, AM Rojek, HEH Møller, NB Palstrøm, CG Nyvold, ... Amyloid 27 (1), 59-66, 2020 | 39 | 2020 |
| Sensitive ligand-based protein quantification using immuno-PCR: a critical review of single-probe and proximity ligation assays MC Hansen, L Nederby, MOB Henriksen, M Hansen, CG Nyvold Biotechniques 56 (5), 217-228, 2014 | 38 | 2014 |
| Characterization and prognostic significance of mitochondrial DNA variations in acute myeloid leukemia T Silkjaer, JM Nørgaard, A Aggerholm, LH Ebbesen, E Kjeldsen, ... European journal of haematology 90 (5), 385-396, 2013 | 34 | 2013 |
| Sensitivity of minimal residual disease in acute myeloid leukaemia in first remission–methodologies in relation to their clinical situation P Hokland, HB Ommen, CG Nyvold, AS Roug British journal of haematology 158 (5), 569-580, 2012 | 34 | 2012 |
| Common variable immunodeficiency unmasked by treatment of immune thrombocytopenic purpura with Rituximab TH Mogensen, JM Bernth-Jensen, CC Petersen, MS Petersen, C Nyvold, ... BMC Blood Disorders 13, 1-9, 2013 | 31 | 2013 |
| Wilms' tumor 1 mutation accumulated during therapy in acute myeloid leukemia: Biological and clinical implications CG Nyvold, J Stentoft, K Brændstrup, D Melsvik, SK Moestrup, ... Leukemia 20 (11), 2051-2054, 2006 | 30 | 2006 |
| A decade with whole exome sequencing in haematology MC Hansen, T Haferlach, CG Nyvold British journal of haematology 188 (3), 367-382, 2020 | 29 | 2020 |
| The Mycoplasma hominis P120 membrane protein contains a 216 amino acid hypervariable domain that is recognized by the human humoral immune response C Nyvold, S Birkelund, G Christiansen Microbiology 143 (2), 675-688, 1997 | 28 | 1997 |
| Analysis of a Mycoplasma hominis membrane protein, P120 G Christiansen, SL Mathiesen, C Nyvold, S Birkelund FEMS microbiology letters 121 (1), 121-127, 1994 | 25 | 1994 |
Marcus Høy HansenOdense University Hospital, University of Southern Denmark, Aarhus UniversityПотвърден имейл адрес: clin.au.dk
